We are a wholly-owned subsidiary of Sumitomo Dainippon Pharma, an R&D-oriented pharmaceutical company focusing on CNS,
oncology and Regenerative Medicine. Sumitomo Dainippon Pharma is one of the group companies of Sumitomo Chemical, a leading company in biotechnology.
Blessed with various collaboration opportunities with their valuable resources, we are well positioned to develop new innovative technologies/products for tomorrow.
Our history goes back to 1974 when a business unit for Diagnostics and Cells was first formed at our predecessor. After several transitions thereafter, the current entity was created in 2001, which changed its name to the present one - DS Pharma Biomedical in 2006.